In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $77.98 in the prior trading day, Insmed Inc (NASDAQ: INSM) closed at $75.54, down -3.13%. In other words, the price has decreased by -$3.13 from its previous closing price. On the day, 2.27 million shares were traded. INSM stock price reached its highest trading level at $77.57 during the session, while it also had its lowest trading level at $74.645.
Ratios:
Our goal is to gain a better understanding of INSM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.61 and its Current Ratio is at 1.80.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on April 23, 2024, initiated with a Buy rating and assigned the stock a target price of $48.
On February 15, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $42.
On December 08, 2023, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $55.Wells Fargo initiated its Overweight rating on December 08, 2023, with a $55 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 10 ’24 when Flammer Martina M.D. sold 21,195 shares for $60.00 per share. The transaction valued at 1,271,700 led to the insider holds 106,134 shares of the business.
Schaeffer Orlov S Nicole sold 55,000 shares of INSM for $3,043,150 on Jun 03 ’24. The Chief People Strategy Officer now owns 108,760 shares after completing the transaction at $55.33 per share. On May 30 ’24, another insider, Flammer Martina M.D., who serves as the Chief Medical Officer of the company, sold 21,195 shares for $55.00 each. As a result, the insider received 1,165,725 and left with 106,134 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSM now has a Market Capitalization of 12720029696 and an Enterprise Value of 11997533184. For the stock, the TTM Price-to-Sale (P/S) ratio is 38.60. Its current Enterprise Value per Revenue stands at 38.028 whereas that against EBITDA is -17.856.
Stock Price History:
Over the past 52 weeks, INSM has reached a high of $78.87, while it has fallen to a 52-week low of $20.16. The 50-Day Moving Average of the stock is 45.34%, while the 200-Day Moving Average is calculated to be 128.19%.
Shares Statistics:
The stock has traded on average 3.67M shares per day over the past 3-months and 2920560 shares per day over the last 10 days, according to various share statistics. A total of 161.23M shares are outstanding, with a floating share count of 156.79M. Insiders hold about 2.75% of the company’s shares, while institutions hold 92.33% stake in the company. Shares short for INSM as of 1719532800 were 12828851 with a Short Ratio of 3.50, compared to 1717113600 on 10856976. Therefore, it implies a Short% of Shares Outstanding of 12828851 and a Short% of Float of 7.9799999999999995.
